Alfresa Holdings Corporation stock reports JPY 788.96 billion revenue

Alfresa Holdings Corporation reported JPY 788.96 billion in revenue for the first quarter of fiscal 2027, while net income was JPY 2.48 billion. The latest figures place earnings at the center of the stock story as the company moves toward its next reporting milestone.

Revenue reached JPY 788.96 billion

According to Investing.com in its latest earnings summary, Alfresa reported JPY 788.96 billion in Q1 FY27 revenue, compared with JPY 740.98 billion in the previous quarter. That represents a sequential increase of 6.48 percent and shows that sales volume remained resilient across the group's healthcare distribution operations.

The earnings quality was weaker than the revenue trend. Net income fell to JPY 2.48 billion from JPY 9.77 billion in the previous quarter, a decline of 74.64 percent, while quarterly EPS stood at JPY 13.85, according to Investing.com. The contrast between higher revenue and lower profit makes margins and operating costs the key figures for the next update.

Dividend date sets the near term

Futu Information reported that Alfresa went ex dividend on September 29, 2026, for a JPY 35.00 per share payment, with the shareholder record date set for September 30, 2026. The ex-dividend date gives the stock a concrete event marker even as investors weigh the sharp quarter-to-quarter profit comparison.

Alfresa operates in healthcare distribution, with activities spanning prescription drugs, self-medication products, pharmaceuticals, medical devices and pharmacies, according to Yahoo Finance. That diversified structure supports the revenue base, but the Q1 figures show that sales growth alone does not determine quarterly profitability.

Stock value and trading context

Alfresa stock was last at JPY 2,281.00 on the Tokyo Stock Exchange on September 29, 2026 at 3:30 p.m. JST. Its market capitalization was JPY 400.1 billion, and the 52-week range was JPY 2,055.00 to JPY 2,685.50 on the same date.